The challenge: SLC6A1 neurodevelopmental disorder is a rare genetic condition caused by mutations in the SLC6A1 gene, which encodes the GAT-1 (gamma-aminobutyric acid transporter 1) protein
Groundbreaking research into Polycystic Kidney Disease (PKD), an inherited condition that often leads to renal failure and requires dialysis or transplant, has led to the creation
Applications close on Friday the 17th of April 2026, 5pm (AEST) 👉 Learn more here: https://phenomicsaustralia.org.au/voucher-scheme/ In this Pipeline Accelerator round, Phenomics Australia is partnering with
The 2025–26 Pipeline Accelerator round will be opening soon. Join us online on Thursday, 12th of March at 12 pm AEST for an information session on the Pipeline Accelerator and Technical Feasibility
Phenomics Australia (formerly the Australian Phenomics Network, APN) offers consolidated infrastructure and expertise supporting genomic medicine and biomedical research from discovery through into early clinical development and evaluation.
Phenomics Australia is a founding capability enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). We would love to hear from you!
Please feel free to provide any ideas or general comments you might have so that we can further improve how Phenomics Australia can support you.
Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.
Information provided will be used to inform press releases, website stories, social media content and more. This form is being used to capture everything that is happening at Phenomics Australia, which can then be used as part of our outreach and communications.
Once you have completed the form, the Communications and Outreach Coordinator will then be in contact with you.
Thanks.
_Get in touch to discuss how we can help with your research.
